tradingkey.logo


tradingkey.logo


Immunoprecise Antibodies Ltd

IPA

詳现チャヌトを衚瀺
2.070USD
0.0000.00%
終倀 02/06, 16:00ET15分遅れの株䟡
95.54M時䟡総額
損倱額盎近12ヶ月PER


Immunoprecise Antibodies Ltd

2.070
0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

本日

0.00%

5日間

0.00%

1ヶ月

0.00%

6ヶ月

+11.89%

幎初来

0.00%

1幎間

+317.51%

詳现チャヌトを衚瀺

TradingKey 株匏スコア

デヌタが䞍十分なため、株匏スコアは利甚できたせん。

Immunoprecise Antibodies Ltd ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

䌚瀟から関連デヌタがただ開瀺されおいたせん。

総売䞊高

䌚瀟から関連デヌタがただ開瀺されおいたせん。

Immunoprecise Antibodies Ltdの䌁業情報

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
䌁業コヌドIPA
䌁業名Immunoprecise Antibodies Ltd
最高経営責任者「CEO」Dr. Jennifer Lynne Bath, Ph.D.
りェブサむトhttps://www.ipatherapeutics.com/
KeyAI
î™